Immune Checkpoint Inhibitor Efficacy in BRAF-Mutant NSCLC Immune Checkpoint Inhibitor Efficacy in BRAF-Mutant NSCLC
Various immune checkpoint inhibitors are used in the treatment of non-small cell lung cancer, but how effective are they in patients with BRAF mutations?Translational Lung Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Health | Hematology | Lung Cancer | Non-Small Cell Lung Cancer